Introduction: Secondary prevention after acute myocardial infarction may include cardiac rehabilitation and lifestyle changes. Cardiac rehabilitation has mainly taken place in hospitals without coordination with primary healthcare. Motivational interviews have been shown to be effective as a means for change in patients after acute myocardial infarction. The objective of this study is to evaluate the effectiveness of a cardiac rehabilitation program with motivational interviews in patients discharged from hospital after acute myocardial infarction. Methods: Randomized clinical non-pharmacological trial. A minimum sample of 284 participants requiring cardiac rehabilitation after acute myocardial infarction in six primary healthcare centers. Participants will be randomized to cardiac rehabilitation with motivational interviews or normal standard of care. All secondary results will be evaluated at 1,3 and 6 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
284
The new CR program with MI will be structured in 4 sessions and an optional fifth during the six months after discharge. The methodology of the MI sessions will follow the four phases logical sequence of MI proposed by Rollnick and Millner. 1) engage in a collaborative relationship, 2) focus on a particular change, 3) evoke intrinsic motivations for change, and 4) plan an immediate step for change
All patients in the control group will receive a kit with informative material with the actions and procedures to follow (diet, physical activity, smoking cessation, and other recommendations about secondary prevention).
Centre Atenció Primària de Les Corts
Barcelona, Spain
RECRUITINGCAP Compte Borrell
Barcelona, Spain
NOT_YET_RECRUITINGCentre Atenció Primària Montengre
Barcelona, Spain
RECRUITINGCentre Atenció Primària Casanova
Barcelona, Spain
RECRUITINGPhysical functional capacity
Improvement in aerobic capacity and resistance, measured by a physical effort test
Time frame: 1st month
Physical functional capacity
Improvement in aerobic capacity and resistance, measured by a physical effort test
Time frame: 6th month
Effectiveness of secondary prevention
Effectiveness of secondary prevention will be considered (Satisfied / no satisfied) with next conditions (all together): Blood pressure values \<140/90mmHg, plasma cholesterol c-LDL\<70mg/dL, plasma glycosylated hemoglobin \<7%. Absolute cessation or no initiation of smoking Body Mass Index in the range of 18.5-25kg/m\^2.
Time frame: 1st month
Effectiveness of secondary prevention
Effectiveness of secondary prevention will be considered (Satisfied / no satisfied) with next conditions (all together): Blood pressure values \<140/90mmHg, plasma cholesterol c-LDL\<70mg/dL, plasma glycosylated hemoglobin \<7%. Absolute cessation or no initiation of smoking Body Mass Index in the range of 18.5-25kg/m\^2.
Time frame: 3rd month
Effectiveness of secondary prevention
Effectiveness of secondary prevention will be considered (Satisfied / no satisfied) with next conditions (all together): Blood pressure values \<140/90mmHg, plasma cholesterol c-LDL\<70mg/dL, plasma glycosylated hemoglobin \<7%. Absolute cessation or no initiation of smoking Body Mass Index in the range of 18.5-25kg/m\^2.
Time frame: 6th month
Psychological status
Measured with the Psychological General Well-Being Index (PGWBI)
Time frame: 6th month
Perceived quality of life
Physical and mental summaries of perceived quality of life measured with the generic quality of life Short Form questionnaire (SF-12).
Time frame: 1st month
Perceived quality of life
Physical and mental summaries of perceived quality of life measured with the generic quality of life Short Form questionnaire (SF-12).
Time frame: 2nd month
Perceived quality of life
Physical and mental summaries of perceived quality of life measured with the generic quality of life Short Form questionnaire (SF-12).
Time frame: 3rd month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.